key: cord-0962797-9rgnwwgh
authors: Wang, Y.; Jin, C.; Wu, C. C.; Zhao, H.; Liang, T.; Liu, Z.; Jian, Z.; Li, R.; Wang, Z.; Li, F.; Zhou, J.; Cai, S.; Liu, Y.; Li, H.; Li, Z.; Liang, Y.; Zhou, H.; Wang, X.; Ren, Z.; Yang, J.
title: Organizing Pneumonia of COVID-19: Time-dependent Evolution and Outcome in CT Findings
date: 2020-05-26
journal: nan
DOI: 10.1101/2020.05.22.20109934
sha: ebc44c9e928f3e30d8de3a322ea32c44a84be4ef
doc_id: 962797
cord_uid: 9rgnwwgh

Objective: As a pandemic, a most-common pattern resembled organizing pneumonia (OP) has been identified by CT findings in novel coronavirus disease (COVID-19). We aimed to delineate the evolution of CT findings and outcome in OP of COVID-19. Materials and Methods: 106 COVID-19 patients with OP based on CT findings were retrospectively included and categorized into non-severe (mild/common) and severe (severe/critical) groups. CT features including lobar distribution, presence of ground glass opacities (GGO), consolidation, linear opacities and total severity CT score were evaluated at three time intervals from symptom-onset to CT scan (day 0-7, day 8-14, day>14). Discharge or adverse outcome (admission to ICU or death), and pulmonary sequelae (complete absorption or lesion residuals) on CT after discharge were analyzed based on the CT features at different time interval. Results: 79(74.5%) patients were non-severe and 103(97.2%) were discharged at median day 25 (range, day 8-50) after symptom-onset. Of 67 patients with revisit CT at 2-4 weeks after discharge, 20(29.9%) had complete absorption of lesions at median day 38 (range, day 30-53) after symptom-onset. Significant differences between complete absorption and residuals groups were found in percentages of consolidation (1.5% vs. 13.8%, P=0.010), number of involved lobe >3 (40.0% vs. 72.5%, P=0.030), CT score >4 (20.0% vs. 65.0%, P=0.010) at day 8-14. Conclusions: Most OP cases had good prognosis. Approximately one-third of cases had complete absorption of lesions during 1-2 months after symptom-onset while those with increased frequency of consolidation, number of involved lobe>3, and CT score >4 at week 2 after symptom-onset may indicate lesion residuals on CT.

Since late December 2019, the ongoing outbreak of Coronavirus Disease 2019 (COVID-19) related pneumonia, caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV), has rapidly expanded throughout worldwide (1) (2) (3) . By 29 April 2020, a total of 3.01 million patients with confirmed COVID-19 pneumonia and 207,973 deaths have been reported (4) . Clinical and radiological characteristics of COVID-19 pneumonia have been systematically described. It is noting that the most common findings on chest computed tomography (CT), i.e. peripheral ground glass opacity (GGO), consolidation or both predominantly in bilateral and multifocal distributions highly resembled to a CT pattern of organizing pneumonia (OP) (5,6). As a common lung injury, most cases of OP were demonstrated to have a good prognosis, while permanent damage and interstitial fibrosis were still observed in scare severe cases (7).

Similar prognosis was observed in COVID-19, i.e. above 80% of cases had been discharged with recovery (8). Despite this, prognosis of OP pattern in including radiological outcome and disease course relating to resolution of pulmonary lesions remains currently unclear.

A plenty of studies have explored the evolution of pulmonary lesions based on chest CT (9,10). As the disease progresses, increased number, extent and density of GGOs on CT have been observed (11). Among these, consolidation was considered as an indication of poor prognosis (12). However, evolutions of OP pattern in and the relations with radiological outcome have not been well described. This study therefore aimed to delineate the time-dependent evolution of CT findings and outcome in COVID-19 patients with OP pattern.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint

This retrospective study was approved by the institutional review board and informed patients' consent was waived with approval. 158 laboratory-confirmed patients with COVID-19 pneumonia who underwent chest CT scans between 22 January 2020 and 16 March 2020 were collected from eight hospitals in China. Among the patients, 75

were from Xi'an region; 18 were from Ankang region; 17 were from Hanzhong region; 10 patients were from Baoji region, and 38 patients were from Wuhan region.

A case of COVID-19 was confirmed by a positive result on next-generation sequencing or real-time RT-PCR. The pulmonary lesions were considered to belong to OP pattern based on baseline CT: (1) peripheral predominantly GGO, consolidation or both, with subpleural or bronchovascular bundles distribution ( Figure 4 ); (2) lobar involvement characterized by the total CT score less than or equal to 10 (Evaluation for total CT score detailed below). Unqualified CT images and CT characteristics unmatched with OP pattern were excluded.

According to clinical classification from preliminary diagnosis and treatment protocols for novel coronavirus pneumonia (7th edition) of the National Health Commission, China (13) , all patients were assessed as mild, common, severe and critical types and categorized into non-severe (mild/common) and severe (severe/critical) groups. For mild patients, clinical symptoms are subtle and no pneumonia found on chest imaging. Patients with common type show symptoms such as fever and respiratory tract, and lung opacities on chest imaging. Patients with severe type should meet any of the following conditions: (1) respiratory distress, RR ≥ 30 beats / min; (2) resting blood oxygen saturation ≤ 93%; or (3) partial pressure of arterial blood oxygen (PaO2)/oxygen concentration (FiO2) ≤ 300 mmHg. Critical patients should meet one of the following criteria: (1) respiratory failure with . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. All the patients were diagnosed, isolated and hospitalized, which included initiation of antivirals, interferon, Chinese herbal medications, supplemental oxygen (13) . The discharge criteria were: (1) body temperature returned to normal for greater than 3 days; (2) respiratory symptoms significantly improved; (3) pulmonary imaging showed obvious improvement in acute exudative lesions; (4) two consecutive negative COVID-19 nucleic acid tests at least 24 h apart. The discharged patients were recommended to quarantine for two weeks and then revisit the hospital with nucleic acid test and chest CT scan at 2 and 4 weeks after discharge (13) . The pulmonary sequelae, i.e. complete absorption or residuals with linear opacities, and/or a few GGO with/without consolidation on revisit CT were evaluated. The disease course was defined as the interval from symptom onset to discharge.

Chest CT scans were performed in 16 

Two experienced radiologists with respective 5 and 10 years of thoracic imaging experiences reviewed and described CT findings according to a peer-reviewed literature of viral pneumonia (9,11). The following terms were used: pure GGO; pure . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint consolidation; GGO and consolidation; pure linear opacity; GGO and linear opacity; consolidation and linear opacity; GGO, consolidation and linear opacity; crazy paving pattern; reversed halo pattern. The pulmonary abnormalities involvement was quantitatively estimated by a semi-quantitative scoring system (14) . Each of the five lung lobes was visually scored from 0 to 4 as: 0, no involvement; 1, <25% involvement; 2, 25%-49% involvement; 3, 50%-75% involvement; 4, >75% involvement. The sum of the individual lobar scores were the total CT scores, which ranged from 0 (no involvement) to 20 (maximum involvement).

CT findings were designated to three time groups based on the time from symptom onset to CT scan (day 0-7, day 8-14, day >14).

Continuous variables were presented as mean±standard deviation and the categorical variables were presented as the number and percentage of the total. Differences of CT findings across time groups (day 0-7, day 8-14, day >14), between non-severe and severe cases, between complete absorption and residuals groups were analyzed by Chi-square test, Fisher's exact test, dependent sample t-test or Mann-Whitney U test as appropriate. Multiple comparisons were corrected by Bonferroni correction.

Continuous variable on CT images, i.e. total CT score with significant difference in two-group comparison was further treated as categorical variable using an optimal threshold to maximize the Youden index of the receiver operating characteristic (ROC) analysis in discrimination of complete absorption vs. residuals groups.

All the statistical analyses were performed in the IBM SPSS Statistics Software (version 22; IBM, New York, USA). P<0.05 was considered statistically significant.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. 

Of 1285 lesions in 106 patients, pure GGO (32.2%) was the predominant CT finding, followed by the mixed GGO and consolidation (21.2%), mixed GGO, consolidation and linear opacity (17.7%). Pure linear opacity, reversed halo signs and crazy paving were rare, accounting for 1.9%, 2.2% and 2.0% respectively. Mean total CT score was 5.1±2.8. For number of involved lobes, the lesions were mostly located in bilateral lower lobes (right, 24.7%; left, 22.8%) (Table S1 ).

Significant differences of pure GGO, pure consolidation, pure linear opacity, mixed consolidation and linear opacity, involvement of lung lobes and total CT score were found among the three time groups (day 0-7, day 8-14, day >14) (all P<0.05). From day 0-7 to day 8-14, the percentage of pure GGO significantly decreased (41.4% vs.

30.6%, P=0.002); despite no significance with Bonferroni correction, involvement of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint lung lobes and CT score remarkably increased. From day 8-14 to day >14, the percentage of pure liner opacity significantly increased (1.0% vs. 3.3%, P=0.03) Table S2 ).

Significant differences between non-severe and severe cases were found in terms of age (44.8±13.5 vs. 59.9±12.5 years, P<0.001), presence of comorbidity (27.5% vs.

59.3%, P=0.006), symptom of chest tightness and/or breath shortness (13.9% vs.

40.7%, P=0.003) and decreased lymphocyte count (30.8% vs. 61.5%, P=0.005) ( Table   2 ).

There were 1031 and 254 lesions in non-severe and severe cases, respectively. The percentage of mixed GGO and consolidation and pure consolidation were significantly lower in non-severe group than those in severe group (19.3% vs. 28.7%, P=0.001; 10.6% vs. 15.4%, P=0.030), while percentage of mixed GGO and linear opacity, mixed consolidation and linear opacity, mixed three signs were significantly higher in non-severe than severe groups (7.4% vs. 2.8%, P=0.007; 10.4% vs. 3.5%, P=0.001; 19.7% vs. 29.4%, P<0.001). The number of affected lobes>3 and total CT score were significantly lower in non-severe than severe groups (59.3% vs. 89.1%, P<0.001; 4.7±2.5 vs. 7.5±2.9, P<0.001) ( Table 2) .

Significant difference between complete absorption and residuals groups were found in age (34.9±9.0 vs. 47.9±13.7, P=0.001), elevated C-reactive protein (31.6% vs.

70.5%, P=0.009) and neutrophil percentage (10.0% vs. 37.0%, P=0.020) ( Table 3) .

At day 0-7, 81 and 185 lesions were found on CT in complete absorption and residual groups, respectively. Percentage of pure consolidation was significantly higher in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint complete absorption than residuals groups (14.8% vs. 5.9%, P=0.02) (Figure 3 , Table   S3 ).

A total of 65 and 269 lesions in complete absorption and residuals groups were found at day 8-14. Significant differences between complete absorption and residuals groups were found in percentage of mixed GGO and consolidation (33.8% vs. 21.6%, P=0.04), percentage of pure consolidation (1.5% vs. 13.8%, P=0.01), percentage of affected lobe number>3 (40.0% vs. 72.5%, P=0.03) (Figure 3 , Table S3 ). In addition, ROC curve analysis estimated a cutoff CT score of 4 to discriminate the complete absorption from residuals groups at day 8-14 (AUC=0.732, P=0.006) ( Figure S1 ).

Significantly higher percentage of CT score >4 was found in residuals than complete absorption groups (65.0% vs. 20.0%, P=0.001) ( Figure 3 , Table S3 ).

With regard to the most common OP pattern in COVID-19, this study systematically described the clinical characteristics and time-dependent evolution of CT findings, as well as later outcome of patients. Results indicated that 74.5% of OP cases were non-severe and 97.1% cases had good prognosis with recovery. As for pulmonary resolution, approximately one-third of OP cases had complete absorption of lesions during day 30-53 after symptom onset while those with increased percentages of consolidation, number of involved lung lobe >3, and CT score >4 at week 2 after onset are prone to have pulmonary residuals.

Being consistent with previous finding of COVID-19 (14), the dominant finding in OP pattern was the presence of GGO, followed by mixed GGO and consolidation, with peripheral and lower lobes distribution. In addition, time-dependent evolution indicated that percentage of GGO decreased while that of mixed GGO and consolidation increased from 1 to 2 weeks after onset, and linear opacity increased . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint from 2 to 3 weeks after onset. These findings were in accordance with prior reports regarding the radiological aggravation (≤2 weeks) and improvement (>2 weeks) in COVID-19 (9,10). A systematic review in COVID-19 also observed that GGO turned into extensive consolidation with greatest severity at around day 10 after onset and consolidation gradually resolved after 2 weeks (15) . Histopathologically, alveolar epithelium injured, inflammatory component, fibrin deposition and matrix leaked and coagulated in early and advanced stage and then gradually receded and resorbed during the late disease course (16) , which may explain the primary CT findings in OP pattern.

In COVID-19, 74.5% of OP pattern cases were non-severe which was in agreement with the mild degree of lung injury in most OP cases (17) . In addition, severe cases had older age, more prevalence of comorbidity, and decreased lymphocyte count than non-severe cases. Besides, more prevalence of mixed GGO and consolidation, and pure consolidation with higher lung severity were found in severe cases, whereas non-severe cases showed more prevalence of linear opacity. This may imply a progressive pulmonary involvement in severe cases while a reparative process in non-severe cases. It may be such facts that led to the longer course of disease from symptom onset to discharge in severe than non-severe cases (36.5±9.9 vs. 23.9±7.4 days, P<0.001).

As for clinical outcome, most of OP pattern cases showed good prognosis with discharge. This resembled the previous study of OP (17) . It is noting that for 3 patients with adverse outcomes, they had progressively diffuse GGO and consolidation with interlobular septal thickening in both lungs within the first week after onset. This may be linked to a fast progression from OP to diffuse alveolar damage (18). Among the discharged patients, those with increased percentages of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint consolidation, number of involved lung lobe >3, and CT score >4 at week 2 after onset were prone to have pulmonary residuals. What we observed during the first two weeks was probably correlated with the underlying organizing process of lung injury (7). Prior study found that extensive consolidation as well as increased CT score may suggest the disease progression (11,12). In this regard, cases with extensive Although OP cases of COVID-19 had a favourable prognosis, early monitoring and detection of adverse outcomes and radiological sequelae would contribute to the early intervention for those with potential risks to fibrosis, respiratory failure and death (23).

There were several limitations in this study. First was the relatively small sample and retrospective nature. A larger sample is required to further validate the findings . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint regarding OP of COVID-19. Second, the follow-up period for patients is relatively short and many of residual lesions on CT may be reversible, a long-term follow-up in conjunction with lung function tests would help to further clarify the evolution of residual lesions and its relations with lung function. Third, although pathological evidence is scarce, highly resembled CT features of OP were used to define the OP pattern of COVID-19 in this study. Pathological studies are still needed to validate the OP of COVID-19.

In conclusion, as a most common pattern of COVID-19, majority of OP cases were mild or common and had good prognosis. Approximately one-third of OP cases had complete absorption of lesions during 1-2 month after symptom onset while those with increased frequency of pure consolidation, number of involved lung lobe >3, and CT score >4 at week 2 after symptom onset were prone to have pulmonary residuals.

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-repo rts. Accessed April 29, 2020.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. Organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint Note: Unless otherwise indicated, data are reported as the number of patients, with percentages in parentheses. a , data were reported as the mean±standard derivation. Abbreviations: GGO = ground glass opacity; with three signs = GGO, consolidation and linear opacity . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. >3.20 0(0) 0(0)

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. a , data were reported as the mean±standard derivation.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.22.20109934 doi: medRxiv preprint

A Novel Coronavirus from Patients with Pneumonia in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 2019 novel coronavirus infection in China

COVID-19): A Perspective from China

National Health Commission of the People's Republic of China. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV

CT imaging features of 2019 novel coronavirus (2019-NCoV)

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Organizing pneumonia: A kaleidoscope of concepts and morphologies

Cryptogenic and secondary organizing pneumonia: Clinical presentation, radiographic findings, treatment response, and prognosis